Efficacy and Safety of Single and Multiple Doses of Pseudoephedrine in the Treatment of Nasal Congestion associated with Common Cold
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Pseudoephedrine (60 mg) is widely used as an oral decongestant taken in tablet or syrup formulations every 4–6 hours for the treatment of nasal congestion associated with common cold and allergy. However, there are relatively few studies in the literature that have used objective measures of nasal airway resistance (NAR) to assess the efficacy of pseudoephedrine, and most studies use only a single dose of medication. The present study has the aims of studying the safety and efficacy of a new pseudoephedrine formulation after single and multiple doses in patients with URTI. Methods: The study was a double-blind, randomized, parallel-group, placebo-controlled trial conducted over three study days at a single center. Patients suffering from nasal congestion associated with common cold were recruited and total NAR was measured by the technique of posterior rhinomanometry. NAR and subjective scores of nasal congestion were measured at baseline and after dosing with study medication, every hour over a four-hour period on day 1 after a single dose, and on day 3 after multiple doses of medication. Subjective scores of congestion/stuffiness were also made as a summary score at the end of each day of treatment. Results: Two hundred and thirty-eight patients with nasal congestion associated with acute upper respiratory tract infection (URTI), mean age 20 years, were recruited to the study and received treatment. After a single dose on day 1 the pseudoephedrine group had a statistically significant lower area under the NAR curve than placebo (p = 0.006) for the primary efficacy variable area under the NAR curve from 0–3 hours (NAR AUC 0–3h), and similarly for the secondary efficacy variable NAR AUC 0–4h (p = 0.001). On day three after multiple doses, the pseudoephedrine group had a statistically significant lower NAR AUC 0–3h and AUC 0–4h than placebo (p < 0.001), On day 1, the pseudoephedrine group had significantly lower subjective scores for congestion than placebo visual analog scale (VAS) AUC 0–3h (p = 0.029) and similarly for VAS AUC 0–4h (p = 0.021). On day 3, the differences in subjective scores were not significantly different. The mean decrease from baseline of the summary score for congestion/stuffiness over the duration of the study was greater in the pseudoephedrine group compared to the placebo group (p = 0.016). On average, heart rate was between two and four beats per minute greater in the pseudoephedrine group compared to placebo. Five adverse events were reported in both treatment groups and these were deemed to be unrelated to treatment. Conclusion: The results demonstrate that pseudoephedrine is a safe and effective treatment for nasal congestion associated with URTI. The results from the laboratory study on day 1 demonstrate by both objective and subjective measures of nasal congestion that a single dose of 60 mg pseudoephedrine is superior to placebo treatment. Support for the decongestant efficacy of multiple doses of pseudoephedrine is provided by objective measures on day 3 and subjective measures made over three days, but not by the VAS scores on day 3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Horak, F., Toth, J., Marks, B., Stübner, U. P., Berger, U. E., Jäger, S., Burtin, B., & Duby, C. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03990.x · Cited by 32
Cited by
Clinical Practice Guideline (Update): Adult Sinusitis
Rosenfeld, R. M., Piccirillo, J. F., Chandrasekhar, S. S., Brook, I., Ashok Kumar, K., Kramper, M., Orlandi, R. R., Palmer, J. N., Patel, Z. M., Peters, A., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815572097 · Cited by 1,159
Clinical practice guideline: Adult sinusitis
Rosenfeld, R. M., Andes, D., Neil, B., Cheung, D., Eisenberg, S., Ganiats, T. G., Gelzer, A., Hamilos, D., Haydon, R. C., Hudgins, P. A., et al. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2007.06.726 · Cited by 907
Diagnostic tools in Rhinology EAACI position paper
Scadding, G., Hellings, P., Alobid, I., Bachert, C., Fokkens, W., van Wijk, R. G., Gevaert, P., Guilemany, J., Kalogjera, L., Lund, V., et al. (2011) · Clinical and Translational Allergy · doi:10.1186/2045-7022-1-2 · Cited by 220
“Some studies however show corresponding results between rhinomanometry and subjective symptom scoring after inducing (de)congestion [91,92].”
ResultNasal decongestants for the common cold
Taverner, D., & Latte, G. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001953.pub3 · Cited by 134
RetractedNasal decongestants in monotherapy for the common cold
Deckx, L., De Sutter, A. I., Guo, L., Mir, N. A., & van Driel, M. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009612.pub2 · Cited by 107
Metadata
- Authors
- Eccles, R., Jawad, M. S. M., Jawad, S. S. M., Angello, J. T., & Druce, H. M.
- Venue
- American Journal of Rhinology
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 19
- Issue
- 1
- Pages
- 25-31
- ISSN
- 1050-6586 (ISSN-L)
- 1539-6290
- OpenAlex
- W1590322802
- Cited by
- 77
- References
- 1
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and Safety of Single and Multiple Doses of Pseudoephedrine in the Treatment of Nasal Congestion associated with Common Cold. https://app.cochat.ai/papers/10.1177/194589240501900105
- The paper
- Eccles, R., Jawad, M. S. M., Jawad, S. S. M., Angello, J. T., & Druce, H. M. (2005). Efficacy and Safety of Single and Multiple Doses of Pseudoephedrine in the Treatment of Nasal Congestion associated with Common Cold. American Journal of Rhinology. https://doi.org/10.1177/194589240501900105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.